Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin.
Kyeong Hyeon ChunHancheol LeeJung Hwa HongKwon-Duk SeoPublished in: Journal of the American Heart Association (2024)
Our study confirmed that DOACs have a better prognosis than warfarin after ischemic stroke. The apixaban and edoxaban groups had a lower risk of death after ischemic stroke than the other DOAC groups.